- Home
- APP vs SYK Comparison
APP vs SYK Comparison
Compare APP & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APP
- SYK
- Stock Information
- Founded
- APP 2012
- SYK 1941
- Country
- APP United States
- SYK United States
- Employees
- APP N/A
- SYK N/A
- Industry
- APP EDP Services
- SYK Medical/Dental Instruments
- Sector
- APP Technology
- SYK Health Care
- Exchange
- APP Nasdaq
- SYK Nasdaq
- Market Cap
- APP 116.4B
- SYK 139.4B
- IPO Year
- APP 2021
- SYK N/A
- Fundamental
- Price
- APP $342.34
- SYK $383.55
- Analyst Decision
- APP Buy
- SYK Buy
- Analyst Count
- APP 20
- SYK 20
- Target Price
- APP $304.89
- SYK $408.21
- AVG Volume (30 Days)
- APP 4.0M
- SYK 1.3M
- Earning Date
- APP 02-12-2025
- SYK 01-28-2025
- Dividend Yield
- APP N/A
- SYK 0.88%
- EPS Growth
- APP 1098.41
- SYK 38.37
- EPS
- APP 3.31
- SYK 9.33
- Revenue
- APP $4,289,729,999.00
- SYK $21,974,000,000.00
- Revenue This Year
- APP $41.33
- SYK $11.30
- Revenue Next Year
- APP $22.48
- SYK $8.08
- P/E Ratio
- APP $103.48
- SYK $41.11
- Revenue Growth
- APP 41.48
- SYK 10.51
- 52 Week Low
- APP $40.71
- SYK $307.23
- 52 Week High
- APP $417.64
- SYK $398.20
- Technical
- Relative Strength Index (RSI)
- APP 55.37
- SYK 62.50
- Support Level
- APP $307.07
- SYK $359.32
- Resistance Level
- APP $362.45
- SYK $368.82
- Average True Range (ATR)
- APP 16.82
- SYK 6.66
- MACD
- APP -2.16
- SYK 2.65
- Stochastic Oscillator
- APP 63.69
- SYK 90.39
About APP Applovin Corporation
AppLovin Corp is a mobile app technology company. It focuses on growing the mobile app ecosystem by enabling the success of mobile app developers. The company's software solutions provide tools for mobile app developers to grow their businesses by automating and optimizing the marketing and monetization of their applications.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.